Detalles de la búsqueda
1.
Randomized, double-blind, placebo-controlled study to assess the efficacy and safety of vortioxetine in Japanese patients with major depressive disorder.
Psychiatry Clin Neurosci
; 74(2): 140-148, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31725942
2.
Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson's disease.
J Neural Transm (Vienna)
; 126(3): 299-308, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30689042
3.
Randomized, double-blind, placebo-controlled 8-week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder.
Psychiatry Clin Neurosci
; 72(2): 64-72, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28858412
4.
Randomized, 8-week, double-blind, placebo-controlled trial of vortioxetine in Japanese adults with major depressive disorder, followed by a 52-week open-label extension trial.
Psychiatry Clin Neurosci
; 72(2): 103-115, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29160598
5.
Therapeutic Potential of Vortioxetine for Anhedonia-Like Symptoms in Depression: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan.
Neuropsychiatr Dis Treat
; 18: 363-373, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35221687
6.
Effects of rasagiline on Parkinson's Disease Questionnaire (PDQ-39) emotional well-being domain in patients with Parkinson's disease: A post-hoc analysis of clinical trials in Japan.
PLoS One
; 17(1): e0262796, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35077474
7.
Early Improvement with Vortioxetine Predicts Response and Remission: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan.
Neuropsychiatr Dis Treat
; 17: 3735-3741, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34955641
8.
Therapeutic Potential of Vortioxetine for Anxious Depression: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan.
Neuropsychiatr Dis Treat
; 17: 3781-3790, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34992372
9.
Rasagiline monotherapy in early Parkinson's disease: A phase 3, randomized study in Japan.
Parkinsonism Relat Disord
; 60: 146-152, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30205936
10.
Phase I trial of TAK-385 in hormone treatment-naïve Japanese patients with nonmetastatic prostate cancer.
Cancer Med
; 8(13): 5891-5902, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31429205
Resultados
1 -
10
de 10
1
Próxima >
>>